Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
BACKGROUND: Botulinum neurotoxin A (BoNT-A) may reduce lower limb spasticity but its role in improving walking ability remains to be established. OBJECTIVE: To investigate the efficacy of simultaneous BoNT-A injections into several targeted spastic muscles of different joints on gait speed and on fu...
| Published in: | NeuroRehabilitation Vol. 34; no. 1; pp. 185 - 193 |
|---|---|
| Main Authors: | , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Sage Publications Inc.
2014
|
| Online Access: | View this record in EBSCOhost |